Alerts
PDF
Other content recommended for you
- What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
- NICE is dead; long live NICE
- Addressing ethical challenges in HIV prevention research with people who inject drugs
- Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look
- NICE may fail to stop “postcode prescribing,” MPs told
- Testing relationships: ethical arguments for screening for type 2 diabetes mellitus with HbA1C
- NICE: faster access to modern treatments? Analysis of guidance on health technologies
- From guidance to practice: Why NICE is not enough
- Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile
- NICE recommendations for the assessment of stable chest pain: assessing the early economic and service impact in the rapid-access chest pain service